Evidence map›Paper›PMID 34917256›Full record

ArticleACS medicinal chemistry letters2021

Introducing the Tellurophene-Appended BODIPY: PDT Agent with Mass Cytometry Tracking Capabilities.

Jacob W Campbell, Matthew T Tung, Roberto M Diaz-Rodriguez, Katherine N Robertson, Andrew A Beharry, Alison Thompson

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jacob W CampbellDepartment of Chemistry, Dalhousie University, P.O. Box 15000, Halifax, Nova Scotia B3H 4J3, Canada.
Matthew T TungDepartment of Chemistry and Physical Sciences, University of Toronto, Mississauga, Ontario L5L 1C6, Canada.
Roberto M Diaz-RodriguezDepartment of Chemistry, Dalhousie University, P.O. Box 15000, Halifax, Nova Scotia B3H 4J3, Canada.ORCID https://orcid.org/0000-0002-4778-0687
Katherine N RobertsonDepartment of Chemistry, Saint Mary's University, Halifax, Nova Scotia B3H 3C3, Canada.ORCID https://orcid.org/0000-0002-5602-8059
Andrew A BeharryDepartment of Chemistry and Physical Sciences, University of Toronto, Mississauga, Ontario L5L 1C6, Canada.ORCID https://orcid.org/0000-0003-1505-2375
Alison ThompsonDepartment of Chemistry, Dalhousie University, P.O. Box 15000, Halifax, Nova Scotia B3H 4J3, Canada.ORCID https://orcid.org/0000-0003-4231-3446
Dalhousie University · CAUniversity of Toronto · CASaint Mary's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis and characterization of the first BODIPY appended to the five-membered heterocylic tellurophene [Te] moiety is reported. By incorporating tellurophene at the

Identifiers

PMID34917256
PMCPMC8667306
OpenAlexW3215749697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.